Cytori Therapeutics, Inc., of the United States, is a regenerative-medicine company, based in San Diego. The company develops and manufactures medical devices that enable the therapeutic use of the adult stem and regenerative cells naturally found within adipose (fat) tissue. Commercial activities are focused on cosmetic & reconstructive surgery, cell banking, and supplying research tools. Cytori Therapeutics, Inc. is a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions. The company was created as the result of a 2002 merger between Macropore Biosurgery Inc. (founded in 1996) and StemSource Inc. (founded in 2000). The joint company operated under the Macropore name until 2005 when it changed its name to Cytori Therapeutics. Cytori is headquartered in San Diego, CA, and also has operations in Japan and the United Kingdom.